
Search
Selected Filters
Filter Results
Displaying 1–10 of 120 news results
-
Mar 2, 2023
The May 11th gala will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
-
Feb 28, 2023
RD Fund Appoints Mark S. Blumenkranz, MD, MMS to Board of Directors
Ophthalmology visionary Mark S. Blumenkranz, MD, MMS, to join RD Fund’s Board.
-
Feb 21, 2023
Foundation Fighting Blindness to Host their Spring VisionWalks
These VisionWalk events taking place this spring will raise awareness and fund research finding treatments and cures for blinding retinal diseases.
-
Feb 13, 2023
The Foundation Makes an Impact on Retinal Research
The Foundation Fighting Blindness’ long-term impact on moving the inherited retinal disease field forward towards treatments and cures.
-
Jan 25, 2023
Foundation Fighting Blindness to Host PRPH2 and Associated Retinal Diseases Workshop
Session to have special translational research emphasis on PRPH2 and inherited macular dystrophies.
-
Jan 6, 2023
The Retinal Degeneration Fund invests in a $78M Series B for Perceive Biotherapeutics
The investment supports the clinical development of two novel programs, both with the aim of being protective against vision loss.
-
Nov 10, 2022
Uni-Rare Study will improve clinical understanding of more IRDs and boost development of potential therapies.
-
Oct 13, 2022
On World Sight Day 2022, Retina International is presenting data from a report on its study into the Socio-economic Impact of late-stage age-related macular degeneration (AMD) in Bulgaria, Germany, and USA.
-
Sep 22, 2022
Initiatives to increase engagement and awareness around blinding retinal diseases.
-
Sep 15, 2022
RD Fund Participates in a €75 Million Series B for SparingVision
Proceeds to fund first, in-human trials of breakthrough gene-agnostic therapy products and advance CRISPR-based genome editing portfolio.